VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 68 filers reported holding VERRICA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 8.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35 | -63.2% | 9,123 | -44.4% | 0.00% | – |
| Q2 2023 | $95 | – | 16,400 | +12712.5% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 128 | -98.4% | 0.00% | – |
| Q1 2022 | $67,000 | -10.7% | 8,235 | 0.0% | 0.00% | – |
| Q4 2021 | $75,000 | -27.2% | 8,235 | 0.0% | 0.00% | – |
| Q3 2021 | $103,000 | +10.8% | 8,235 | +0.2% | 0.00% | – |
| Q2 2021 | $93,000 | -24.4% | 8,218 | +1.4% | 0.00% | – |
| Q1 2021 | $123,000 | +127.8% | 8,107 | +72.5% | 0.00% | – |
| Q4 2020 | $54,000 | +50.0% | 4,700 | 0.0% | 0.00% | – |
| Q3 2020 | $36,000 | -76.3% | 4,700 | -65.9% | 0.00% | – |
| Q2 2020 | $152,000 | +0.7% | 13,800 | 0.0% | 0.00% | – |
| Q1 2020 | $151,000 | -31.1% | 13,800 | 0.0% | 0.00% | – |
| Q4 2019 | $219,000 | +7.4% | 13,800 | 0.0% | 0.00% | – |
| Q3 2019 | $204,000 | +27.5% | 13,800 | 0.0% | 0.00% | – |
| Q2 2019 | $160,000 | +332.4% | 13,800 | +305.9% | 0.00% | – |
| Q1 2019 | $37,000 | +32.1% | 3,400 | 0.0% | 0.00% | – |
| Q4 2018 | $28,000 | – | 3,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,038,983 | $19,576,448 | 0.65% |
| BML Capital Management, LLC | 150,000 | $582,750 | 0.54% |
| Caligan Partners LP | 259,593 | $1,009,817 | 0.46% |
| Avoro Capital Advisors LLC | 2,954,064 | $11,476,539 | 0.18% |
| Boxer Capital, LLC | 166,955 | $648,620 | 0.04% |
| SteelPeak Wealth, LLC | 136,986 | $532,191 | 0.03% |
| Legacy Trust | 18,750 | $72,844 | 0.02% |
| Miracle Mile Advisors, LLC | 118,221 | $459,289 | 0.01% |
| SPC Financial, Inc. | 30,000 | $116,550 | 0.01% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 99,251 | $385,590 | 0.01% |